Mallinckrodt to make $1.2bn acquisition
02-01-2018
Mallinckrodt respiratory patents invalidated by court
06-09-2017
07-08-2017
designer491 / iStockphoto.com
Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Mallinckrodt, mergers & acquisitions, pharmaceuticals, paediatric, jaundice, Food and Drug Administration, InfaCare Pharmaceutical Corporation